Form 4 holding
EVP, Chief Legal Officer
Amneal Pharmaceuticals, Inc.
- Security class
- Performance-Based Restricted Stock Units
- Shares / value
- 0
- Estimated value
- $1,715,526
- Report date
- 03 Mar 2026
- Price
- $8.84
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount